Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.
Endothelin (ET-1) is a potent vasoconstrictor. We compared patterns of ET-1 in percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and correlated it with markers of inflammation. Patients with multivessel disease were enrolled in a prospective randomized study of PCI v...
Autori principali: | Cuculi, F, Lim, C, van Gaal, W, Testa, L, Westaby, S, Arnold, JR, Neubauer, S, Banning, A |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2011
|
Documenti analoghi
Documenti analoghi
-
Do patients undergoing percutaneous coronary intervention still require consenting for emergency coronary bypass surgery?
di: Arnold, J, et al.
Pubblicazione: (2007) -
Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: The endless debate - Reply
di: Kaul, S, et al.
Pubblicazione: (2008) -
Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting
di: Arjomandi Rad, A, et al.
Pubblicazione: (2024) -
Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound?
di: Taggart, D
Pubblicazione: (2007) -
Stents versus bypass grafting for left main coronary artery disease.
di: Arnold, JR, et al.
Pubblicazione: (2008)